Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-11

FDA Approved: BORTEZOMIB — Original Application (Somerset Therapeutics LLC)

View source ↗

Summary

FDA approved a generic version of Bortezomib under an Original Application (ANDA 211898) for Somerset Therapeutics LLC. The product is used for the treatment of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bortezomib (bortezomib)

Snippet

ORIG AP for BORTEZOMIB (BORTEZOMIB)